Clinical Trials Sponsored by Seva Foundation

Total 16620 results

Visualiza
Seva Foundation

Not yet recruiting

Safety and Effectiveness of Drop-free Small Incision Cataract Surgery

Ocular Hypertension | Ocular Inflammation | Cataract | Post-Op Complication
Seva Foundation
Queen's University, Belfast; Bharatpur Eye Hospital; Indian Institute of Public... and other collaborators

Completed

Improving the Follow up Rate for Pediatric Patients

Conjunctivitis | Strabismus | Amblyopia | Corneal Ulcer | Eye Injuries | CNLDO - Congenital Nasolacrimal Duct Obstruction

Nepal
University of California, San Francisco
Seva Foundation; Bharatpur Eye Hospital

Completed

Village-Integrated Eye Worker Trial II - Pilot (VIEW II Pilot)

Glaucoma | Diabetic Retinopathy | Refractive Errors | Cataract | Age Related Macular Degeneration

Nepal
Seva Foundation
Queen's University, Belfast; Dr Shroff's Charity Eye Hospital; Indian Institute... and other collaborators

Completed

Increasing Vision Center Service Utilization

Eye Diseases

India
Seva Foundation
Queen's University, Belfast; Lumbini Eye Institute and Hospital; Indian Institute... and other collaborators

Completed

Improve Timely Referral Flow and Compliance of Diabetic Retinopathy Patients

Diabetes | Diabetic Retinopathy

Nepal
Seva Foundation
Queen's University, Belfast; Indian Institute of Public Health, India; Seva Canada... and other collaborators

Completed

Augmenting Referral Pathway to Improve Uptake of Retinal Services by Diabetic Patients

Diabetic Retinopathy

Nepal
University of California, San Francisco
Seva Foundation; Lumbini Eye Institute and Hospital

Unknown

Micro vs. Standard Trabeculectomy Study

Glaucoma

Nepal
Fondation Ophtalmologique Adolphe de Rothschild
Teva Pharmaceutical Industries, Ltd.

Completed

Feasibility of Continuous Sleep Recording in Patients Undergoing Deep Brain Stimulation for Parkinson's Disease (BRACELET)

Parkinson Disease
Teva Pharmaceuticals USA
Teva Pharmaceuticals, Inc.

Completed

Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris

Acne Vulgaris

United States
Francisco Selva

Completed

Effects of Magnetic Tape on Perceived Spine Pain and Over Ankle Dorsiflexion in Patients With Low Back Pain

Back Pain

Spain
Francisco Selva

Withdrawn

Effects of Magnetic Tape Over Hip Flexion in Patients With Low Back Pain.

Low Back Pain
Francisco Selva

Completed

Changes in Blood Flow in the Application of Magnetic Tape in Patients With Low Back Pain. RCT

Low Back Pain

Spain
Francisco Selva

Withdrawn

Effects of Magnetic Tape Over Internal Hip Rotation in Patients With Low Back Pain

Low Back Pain

Spain
Francisco Selva

Completed

Effects of Magnetic Tape Over Hip Cutaneous Nerves in Patients With Low Back Pain

Low Back Pain

Spain
Francisco Selva

Withdrawn

Effects of Magnetic Tape on Autonomic Nervous System in Patients With Low Back Pain

Low Back Pain

Spain
Francisco Selva

Withdrawn

Effects of Magnetic Tape Over Ankle Dorsiflexion in Patients With Low Back Pain

Low Back Pain

Spain
University of California, San Francisco
National Eye Institute (NEI); Seva Foundation; Bharatpur Eye Hospital

Active, not recruiting

Village Integrated Eye Workers Trial (VIEW)

Corneal Ulcer

Nepal
Teva GTC

Terminated

Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's Disease

Crohn's Disease

Israel
Teva GTC

Completed

Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)

Traumatic Brain Injury

Israel
Teva GTC

Completed

Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients

Crohns Disease

Israel
Teva GTC

Completed

Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease

Crohn's Disease

Israel
Teva Pharma

Completed

Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines

Metastatic Breast Cancer

Belgium
Teva GTC

Withdrawn

Open Label Extension Study to Protocol C2/13/DR-6MP-02 (OLE)

Crohn's Disease
Teva GTC

Terminated

One Year Extension Study To Protocol C2/5/TZ:MS-05

Multiple Sclerosis | Spasticity

Israel
Teva GTC

Completed

Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity

Muscle Spasticity

Israel
Eva Szigethy
Crohn's and Colitis Foundation

Completed

Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease

Fatigue | Sleep Disturbance | Inflammatory Bowel Disease

United States
Teva Pharmaceuticals USA
Teva Pharmaceuticals Development, Inc.

Completed

Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Chronic Urticaria

United States
Universidad Complutense de Madrid
Eklund Foundation; SEPA (Sociedad Española de Periodoncia)

Recruiting

Metabolomic and Proteomic Fingerprinting in Peri-implant Diseases

Peri-Implantitis | Peri-implant Mucositis

Spain
University of California, San Francisco
Seva Foundation; Bharatpur Eye Hospital; Lumbini Eye Institute and Hospital

Recruiting

Village-Integrated Eye Worker Trial II (VIEW II)

Glaucoma | Diabetic Retinopathy | Age-related Macular Degeneration

Nepal
REVA Medical, Inc.

Recruiting

MOTIV BTK Randomized Controlled Trial

Critical Limb Ischemia

United States, Germany
Teva Pharmaceuticals USA

Completed

Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy

Dyspareunia

United States, El Salvador, Honduras
Siva Health AG

Enrolling by invitation

Validation Study With a Non-CE Marked Medical Device (MD)

Chronic Cough

United States
REVA Medical, Inc.

Completed

Pilot Study of the Fantom Bioresorbable Scaffold (FANTOM I) (FANTOM I)

Coronary Artery Disease

Brazil, Poland
Teva Pharmaceuticals USA

Completed

Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Benazepril HCl 40 mg Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Terminated

Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions

Depressive Disorder

United States
Teva Pharmaceuticals USA

Completed

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study

Healthy

Canada
Teva Pharmaceuticals USA

Completed

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.

Healthy

United States
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.

Healthy

United States
Teva Pharmaceuticals USA

Completed

Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Valacyclovir 1000 mg Tablet Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Capsules Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Azithromycin 600 Mg Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Leflunomide 20 mg Tablets, Non-Fasting

Healthy

United States

Clinical Trials Sponsored by Seva Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations